Proskauer

Representative experience:

Mergers and Acquisitions

• Forbes Global Holdings in its proposed business combination with Magnum Opus Acquisition Limited and related $200 million strategic investment from Binance.*
• Cybereason in connection with acquisition of empow Cyber Security.*
• Cybereason in connection with its Series F Financing.*
• Cybereason in connection with its Series E Financing.*
• Volta Technologies in connection with various investments.*
• Forbes Media LLC on its sale of a majority stake to a group of international investors as part of the company's global growth strategy.*
• Acorda Therapeutics, Inc. in its acquisition of Civitas Therapeutics, Inc.*
• Dover Corporation in the reorganization and sale of its business unit, Texas Hydraulics, Inc. to Wynnchurch Capital.*
• Genpact Limited in its acquisition of OnSource LLC.*
• Genpact Limited in its acquisition of TandemSeven, Inc.*
• The Dagim-Go Fish LLC in its sale of The Fishing Company of Alaska, Inc. to Ocean Peace, Inc. and O’Hara Corporation.*
• Towers Watson & Co. in its acquisition of Acclaris.*
• Towers Watson & Co. in its acquisition of Extend Health, Inc.*
• Towers Watson & Co. in its acquisition of Liazon Corporation.*
• Towers Watson & Co. in the sale of its Reinsurance Brokerage business to Jardine Lloyd Thompson Group plc (JLT).*
• Evercore as financial advisor to the Special Committee of the Board of Directors of Genco Shipping & Trading Limited in connection with the sale of preferred stock by Genco to a number of investors, including affiliates of Centerbridge, Apollo and Strategic Value Partners, for an aggregate purchase price of $125 million.*
• Evercore as financial advisor to Höegh LNG Partners LP in connection with a dropdown transaction pursuant to which Höegh LNG Partners purchased from a subsidiary of Höegh LNG Holdings Ltd. a 51% ownership interest in Höegh LNG Colombia Holding Ltd. for a purchase price of $189 million.*
• Evercore as financial advisor to the Special Committee of the Board of Directors of Tanker Investments Ltd. in connection with its sale to Teekay Tankers Ltd. in a share for share exchange.*
• Elan Corporation, plc in the spinoff of its drug discovery business, Prothena Corporation plc.*
• Pfizer, Inc. in its $68 billion acquisition of Wyeth.*
• Pfizer, Inc. in its $3.6 billion acquisition of King Pharmaceuticals, Inc.*
• Pfizer, Inc. in the $16.6 billion sale of its Consumer Healthcare business to Johnson & Johnson.*
• Trian Fund Management in Triarc Companies, Inc.’s acquisition of Wendy’s International, Inc.*
• Nektar Therapeutics in the sale of its royalties on future sales of CIMZIA® and MIRCERA® to Royalty Pharma.*
• Six Flags Entertainment Corporation in its acquisition of an interest in a joint venture that owned Dick Clark Productions, Inc., and in the sale of certain theme parks to PARC 7F-Operations Corporation and CNL Income Properties, Inc.*
• The Bear Stearns Companies, Inc. in its merger with JPMorgan Chase & Co.*
• Credit Suisse USA, Inc. in its acquisition of LIME Financial Services, Ltd.*
• JPMorgan Securities LLC, Centerview Partners LLC, Banc of America Securities LLC, Financo Securities, LLC, Barclays, Lehman Brothers Inc., and Bear Stearns & Co. Inc. in their capacities as financial advisor in connection with various mergers and acquisitions transactions.*

Securities and Shareholder Activism

• Marcato Capital Management LP in its acquisition of a 6% stake in Deckers Outdoor Corporation and proxy contest seeking to elect a minority slate of directors to the company’s board.*
• Marcato Capital Management LP in its acquisition of a 9.9 % stake in Buffalo Wild Wings, Inc. and its successful effort to elect three directors to the company’s board in a proxy contest.*
• Marcato Capital Management LP in its acquisition of a 5.1% stake in Terex Corporation and its subsequent agreement to add a representative of Marcato to the board.
• Safe Bulkers, Inc. in a $17.2 million public offering of common shares.*
• Pershing Square Capital Management in its acquisition of a 7.5% stake in Mondelez International, Inc.*
• Perrigo Company plc in an $80 million sale of ordinary shares of Prothena Corporation plc.*
• Deutsche Bank and other underwriters in Air Products and Chemicals, Inc.'s €300 million senior unsecured notes offering.*
• Elan Corporation plc in its $381 million sale of ordinary shares of Alkermes plc and subsequent $170 million sale of its remaining ordinary shares of Alkermes plc.*
• Elan Corporation plc in a $600 million Rule 144A notes offering and tender offer to purchase approximately $625 million of outstanding notes and related redemption of non-tendering notes. *
• Barclays and the other underwriters in Lorillard Tobacco Company’s $500 million senior unsecured notes offering. *
• Trian Fund Management in its $166 million tender offer for common stock of Wendy’s/Arby’s Group, Inc. *
• Pfizer, Inc. in its $13.5 billion SEC-registered senior unsecured notes offering and $10.5 billion Reg S senior unsecured notes offering to finance its acquisition of Wyeth. *
• The Bear Stearns Companies, Inc. in connection with the Bear Stearns Medium Term Note Program and Reverse Convertible Note Program.* 

*at prior firm